Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Meiyu Bi"'
Autor:
Zhimin Wang, Meiyu Bi, Xiaoshu Zhe, Xiao Wang, Bai Dai, Xiaoyu Han, Bingxu Ren, Hao Liang, Dongjun Liu
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-14 (2024)
Abstract The limited differentiation ability of adipose-derived stem cells (ADSCs) limits their application in stem cell therapy and regenerative medicine. Here, we explore the molecular mechanism by which miR-204-5p regulates ADSCs differentiation i
Externí odkaz:
https://doaj.org/article/4673812b437a4274b536ad9693c9b65a
Autor:
Wei Yue, Xinyu Li, Xiaolu Zhan, Lei Wang, Jihong Ma, Meiyu Bi, Qilong Wang, Xiaoyang Gu, Bingteng Xie, Tong Liu, Hongyan Guo, Xin Zhu, Chen Song, Jie Qiao, Mo Li
Publikováno v:
EBioMedicine, Vol 103, Iss , Pp 105129- (2024)
Summary: Background: Poly(ADP-ribose) polymerase (PARP) inhibitors have emerged as promising chemotherapeutic drugs primarily against BRCA1/2-associated tumours, known as synthetic lethality. However, recent clinical trials reported patients’ survi
Externí odkaz:
https://doaj.org/article/f55d96db75c44ed18021d973d990072d
Publikováno v:
EBioMedicine, Vol 79, Iss , Pp 104001- (2022)
Summary: Ovarian cancer (OC) is a heterogeneous disease with the highest mortality rate and the poorest prognosis among gynecological malignancies. Because of the absence of specific early symptoms, most OC patients are often diagnosed at late stages
Externí odkaz:
https://doaj.org/article/227c9ac032a347fd9af9a43a16964eda
Publikováno v:
EBioMedicine. 79
Ovarian cancer (OC) is a heterogeneous disease with the highest mortality rate and the poorest prognosis among gynecological malignancies. Because of the absence of specific early symptoms, most OC patients are often diagnosed at late stages. Thus, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba3ab841aa596bc16b1d871b8cfe6248
https://pubmed.ncbi.nlm.nih.gov/35439677
https://pubmed.ncbi.nlm.nih.gov/35439677